IL83659A - 8-(substituted benzylamino)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them - Google Patents

8-(substituted benzylamino)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them

Info

Publication number
IL83659A
IL83659A IL83659A IL8365987A IL83659A IL 83659 A IL83659 A IL 83659A IL 83659 A IL83659 A IL 83659A IL 8365987 A IL8365987 A IL 8365987A IL 83659 A IL83659 A IL 83659A
Authority
IL
Israel
Prior art keywords
production
pharmaceutical compositions
compositions containing
xanthine derivatives
substituted benzylamino
Prior art date
Application number
IL83659A
Other languages
English (en)
Other versions
IL83659A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620825A external-priority patent/GB8620825D0/en
Priority claimed from GB878702129A external-priority patent/GB8702129D0/en
Priority claimed from GB878703435A external-priority patent/GB8703435D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL83659A0 publication Critical patent/IL83659A0/xx
Publication of IL83659A publication Critical patent/IL83659A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL83659A 1986-08-28 1987-08-26 8-(substituted benzylamino)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them IL83659A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868620825A GB8620825D0 (en) 1986-08-28 1986-08-28 Organic compounds
GB878702129A GB8702129D0 (en) 1987-01-30 1987-01-30 Organic compounds
GB878703435A GB8703435D0 (en) 1987-02-13 1987-02-13 Organic compounds

Publications (2)

Publication Number Publication Date
IL83659A0 IL83659A0 (en) 1988-01-31
IL83659A true IL83659A (en) 1991-06-10

Family

ID=27263135

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83659A IL83659A (en) 1986-08-28 1987-08-26 8-(substituted benzylamino)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them

Country Status (17)

Country Link
EP (1) EP0258191B1 (ja)
JP (1) JPH0631236B2 (ja)
KR (1) KR880002870A (ja)
AU (1) AU600021B2 (ja)
CA (1) CA1289954C (ja)
DE (1) DE3779374D1 (ja)
DK (1) DK169337B1 (ja)
ES (1) ES2033922T3 (ja)
FI (1) FI87356C (ja)
GR (1) GR3004747T3 (ja)
HU (1) HU199840B (ja)
IE (1) IE60512B1 (ja)
IL (1) IL83659A (ja)
MY (1) MY101830A (ja)
NZ (1) NZ221571A (ja)
PH (1) PH24761A (ja)
PT (1) PT85594B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
GB9210839D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
AU4527996A (en) 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
WO1996018399A1 (en) 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
EP1421084B1 (en) 2001-08-28 2008-05-14 Schering Corporation Polycyclic guanine phosphodiesterase v inhibitors
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1024968B (de) * 1956-03-31 1958-02-27 Asal Fabrik Biolog Und Pharmaz Verfahren zur Herstellung von 7-Ketonyl-8-amino-theophyllinen
AT212847B (de) * 1959-08-13 1961-01-10 Hans Dr Med Voigt Verfahren zur Herstellung des neuen Coffeino-(8)-(β-Phenyl-isopropyl)-amin
FR2157727A1 (en) * 1971-10-29 1973-06-08 Brun Lab Sa Le !,#dimethyl-8-aminopurines - with analgesicantitussive and other theophylline-like activities
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
DE3400951A1 (de) * 1984-01-13 1985-07-18 Robert Bosch Gmbh, 7000 Stuttgart Verfahren und vorrichtung zur drehzahlregelung bei einer brennkraftmaschine
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0258191B1 (en) 1992-05-27
IL83659A0 (en) 1988-01-31
PT85594B (pt) 1990-05-31
HUT47111A (en) 1989-01-30
FI87356B (fi) 1992-09-15
GR3004747T3 (ja) 1993-04-28
JPH0631236B2 (ja) 1994-04-27
PT85594A (en) 1987-09-01
PH24761A (en) 1990-10-01
FI873704A (fi) 1988-02-29
FI873704A0 (fi) 1987-08-26
JPS6363679A (ja) 1988-03-22
AU7744587A (en) 1988-03-03
MY101830A (en) 1992-01-31
IE60512B1 (en) 1994-07-27
DK169337B1 (da) 1994-10-10
ES2033922T3 (es) 1993-04-01
DK448787A (da) 1988-02-29
DK448787D0 (da) 1987-08-27
HU199840B (en) 1990-03-28
DE3779374D1 (en) 1992-07-02
FI87356C (fi) 1992-12-28
KR880002870A (ko) 1988-05-12
NZ221571A (en) 1990-11-27
EP0258191A1 (en) 1988-03-02
AU600021B2 (en) 1990-08-02
IE872296L (en) 1988-02-28
CA1289954C (en) 1991-10-01

Similar Documents

Publication Publication Date Title
IL83659A (en) 8-(substituted benzylamino)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them
IL78605A (en) 8-(substituted phenyl)xanthine derivatives,their preparation and pharmaceutical compositions containing them
HUT46653A (en) Process for producing 8-substituted 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same
ZA877530B (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same as well as processes for production thereof
PT85551A (en) Process for the preparation of antiviral pyrimidine derivatives and of pharmaceutical compositions containing the same
GR871666B (en) Heteroaromatic derivatives of adenosine
EP0302793A3 (en) Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
HUT47276A (en) Process for producing pyrazolo/1,5-a/pyrimidine derivatives and pharmaceutical compositions containing them
IL79934A (en) 8-(substituted benzyl)-1,3,7-trisubstituted xanthine derivatives,their production and pharmaceutical compositions containing them
IL88138A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL80109A0 (en) 6,9-substituted purines,pharmaceutical compositions containing them and processes for their preparation
NZ219971A (en) Tetrahydropyrido (2,3-d pyrimidine derivatives and pharmaceutical compositions
ZA855399B (en) Use of xanthine and thioxanthine derivatives for the preparation of medicaments
AU5436790A (en) Sulfer-containing xanthine derivatives as adenosin antagonists
GR870233B (en) Purine derivatives their production and medicaments containing them
IL84728A0 (en) Triazine derivatives,their manufacture and pharmaceutical compositions containing them
IL83452A0 (en) Pyrimidine derivatives,their manufacture and pharmaceutical compositions containing them
HUT55762A (en) Process for producing substituted or unsubstituted 4/5(-)omega-amino-alkyl/-imidazol derivatives and pharmaceutical compositions containing them
IL72848A (en) 2-(2-naphthalenyl)imidazo(4,5-c)pyridine,8-(2-naphthalenyl)purine and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL82099A0 (en) Substituted 1,3,5-triazine derivatives,processes for their preparation,and pharmaceutical compositions containing them
IL88854A (en) Pyrimidine and purine 1,2-butadiene-4-ol derivatives and pharmaceutical compositions containing the same
IL70651A (en) 7-(2-arylethenyl)-5-oxo-5h-thiazolo(3,2-a)pyrimidine-2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0242551A3 (en) Process for the preparation of diaziridines and their derivatives
NZ226785A (en) Isoxazolo(4,5-c azepine derivatives and pharmaceutical compositions
IL89063A0 (en) Ergoline derivatives,their production and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void